The latest health and social care news and a look at research and development into the treatment of common and rare diseases alike. We also look at the vital changes being made to help deliver effective healthcare through the digital transformation within the NHS.
A groundbreaking AI system has been developed to identify patient safety concerns across the NHS, aiming to prevent harm and improve care outcomes through early intervention.
Zillah Moore, Director at Tunstall Healthcare, discusses the role of technology-enabled care services and remote patient monitoring in reducing delayed discharge from hospitals and providing much-needed assistance to the NHS.
The Lancet report is out today (11 February), which suggests that former President Trump's policymaking created an excess of "461,100 deaths" - before the COVID-19 pandemic hit the United States.
The legislative changes in the white paper released today (11 February) include giving local and central Government more control over the NHS - which is expected to be implemented in 2022.
The World Health Organisation have suggested that the Oxford and AstraZeneca vaccine can be safely used for all age groups, including those aged 65 and over.
New research by the American Heart Association finds that obesity is a factor in almost half of all new cases, with obese individuals significantly more likely to get Type 2 diabetes.
Karlo Jacutan, on behalf of Dental Arch, comments on the importance of promoting oral health among populations during the COVID-19 pandemic and restorative dentistry.
The science and art of dispensing optics are ever dynamic, writes Daryl Newsome from the Association of British Dispensing Opticians. Opticians must adopt new technology, adapt their practice of dispensing and take ownership of innovation, he argues.
Zisis Kozlakidis, International Agency for Research on Cancer, with Erik Steinfelder, Thermo Fisher Scientific, chart the challenges in healthcare logistics in relation to COVID-19.
The new results led to the South African Government suspending use of AstraZeneca in their vaccination programme, as it is no longer able to stop the mutation - but could still prevent hospitalisation and fatality.
